Gunilla Enblad
Department of Oncology
Radiology and Clinical Immunology
Uppsala University Hospital
Sweden
Name/email consistency: high
- The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma. Enblad, G., Molin, D., Glimelius, I., Fischer, M., Nilsson, G. Hematol. Oncol. Clin. North Am. (2007)
- A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A.P., Repp, R., Schetelig, J., Seipelt, G., Osterborg, A. Blood (2004)
- Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy. Enblad, G., Gustavsson, A., Sundström, C., Glimelius, B. Acta. Oncol (2002)
- Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Enblad, G., Sandvej, K., Sundström, C., Pallesen, G., Glimelius, B. Acta. Oncol (1999)
- Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study. Enblad, G., Hagberg, H., Gustavsson, A., Glimelius, B. Eur. J. Haematol. (1998)
- Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Enblad, G., Sandvej, K., Lennette, E., Sundström, C., Klein, G., Glimelius, B., Pallesen, G. Int. J. Cancer (1997)